June 22, 2022
Onset of nightmares or distressing dreams in older adults may be a very early sign of Parkinson’s disease (PD), new research suggests. Investigators analyzed 12-year follow-up […]
June 22, 2022
In the United States, the cost of brand-name medications for treating epilepsy soared during the period 2010–2018, while the cost of generic antiseizure medications (ASMs) decreased, […]
June 22, 2022
More experience with bodychecking does not protect young ice hockey players against injury such as concussion, new data indicate. In a prospective cohort study of more […]
June 21, 2022
NATIONAL HARBOR, Maryland ― The latest updates on COVID-19 vaccination response among patients with multiple sclerosis (MS) who are treated with disease-modifying therapy (DMT) show that […]
June 20, 2022
NATIONAL HARBOR, Maryland — The first randomized trial to examine whether older adults with multiple sclerosis (MS) can safely discontinue disease-modifying therapy (DMT) after years of […]
June 17, 2022
In a surprising discovery that flies in the face of conventional medicine, McGill University researchers report that treating pain with anti-inflammatory medication, like ibuprofen or aspirin, […]
June 17, 2022
Almost a third of patients with migraine have experienced some form of stigma, new research shows. Results from the OVERCOME population-based survey study, which included more […]
June 16, 2022
The study covered in this summary was published on medrxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Inteleukin-6 (IL-6) can be […]
June 16, 2022
CHARLOTTE, N.C. — Erratic sleep patterns over years or even decades, along with a patient’s age and history of depression, may be harbingers of cognitive impairment later […]